OTHER STANDARD IDENTIFIER
Standard Number
5826
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Cancer drug development
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York
Name of Publisher, Distributor, etc.
Academic Press
Date of Publication, Distribution, etc.
1979-
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
v.: ill
SERIES
Series Title
Methods in cancer research; v.61-
GENERAL NOTES
Text of Note
Includes bibliographies and index
NOTES PERTAINING TO TITLE AND STATEMENT OF RESPONSIBILITY
Text of Note
edited by Vincent T. DeVita, Jr. and Harris Busch
TOPICAL NAME USED AS SUBJECT
Entry Element
Chemotherapy ، Cancer
Entry Element
Testing ، Antieoplastic agents
Entry Element
، Antieoplastic agents
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC
271
.
C5
PERSONAL NAME - PRIMARY RESPONSIBILITY
Relator Code
TI
AU Devita, Vincent T.
AU Busch, Harris
SE
LOCATION AND CALL NUMBER
Call Number Suffix
Medicine
